3,7-Dimethyl-1-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione

Catalog No. :
ACFCUI703
CAS No. :
6493-05-6
Molecular Formula :
C13H18N4O3
Molecular Weight :
278.31

IUPAC Name:3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione

3,7-Dimethyl-1-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g99%$125.00Login to see priceIn stockIn stock
100g99%$414.00Login to see priceIn stockIn stock
500g99%$1573.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,7-Dimethyl-1-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione
IUPAC Name3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
MDL No.MFCD00063379
Molecular FormulaC13H18N4O3
Molecular Weight278.31
SMILESO=C(N1CCCCC(C)=O)N(C)C2=C(N(C)C=N2)C1=O
InChI KeyBYPFEZZEUUWMEJ-UHFFFAOYSA-N
Synonympentoxifylline | Trental | 6493-05-6 | Oxpentifylline | Pentoxifyllin | Pentoxyphylline | Torental | Pentoxiphyllium | Vazofirin | Dimethyloxohexylxanthine | 3,7-Dimethyl-1-(5-oxohexyl)xanthine | Pentoxiphyllin | Pentoxiphylline | Pentoxyfylline | 1-(5-Oxohexyl)theobromine | Rentylin |
CAS No.6493-05-6
PubChem CID4740

Synthetic Route by SureRoute

1. ACFCUI703 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXBDS067 route compound structure diagram
    ACXBDS06710226-29-6 In Stock
  2. Plus
  3. ACRKWU679 route compound structure diagram
    ACRKWU67983-67-0 In Stock
  4. Then
  5. ACFCUI703 route product structure diagram
    ACFCUI7036493-05-6 In Stock
Inquiry

2. ACFCUI703 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWHAS638 route compound structure diagram
    ACWHAS63810226-30-9 In Stock
  2. Plus
  3. ACRKWU679 route compound structure diagram
    ACRKWU67983-67-0 In Stock
  4. Then
  5. ACFCUI703 route product structure diagram
    ACFCUI7036493-05-6 In Stock
Inquiry

Comments (0)